(2022) Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER). Journal of Antimicrobial Chemotherapy. pp. 758-766. ISSN 0305-7453